Literature DB >> 176410

Effect of phosphonoacetate on Marek's disease virus replication.

L F Lee, K Nazerian, S S Leinbach, J M Reno, J A Boezi.   

Abstract

Phosphonoacetate (PA), but not any of its analogues tested, effectively inhibited avian herpesvirus replication and viral DNA synthesis in cell cultures. At 100 mug/ml culture medium, PA completely inhibited the replication of Marek's disease virus (MDV), herpesvirus of turkeys, and owl herpesvirus, but had no measurable effect on normal cell growth. PA also inhibited DNA polymerases induced by these avian viruses. Enzyme inhibition was 50% at a PA concentration of 0.2 mug/ml. At a concentration of 3-6 mug/ml, the compound also effected a 50% inhibition of alpha (maxi) enzyme of the host DNA polymerase. It had no effect on the host beta (mini) enzyme. When administered to chickens, PA did not inhibit the replication of MDV, nor did it prevent the development of lymphoma.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 176410     DOI: 10.1093/jnci/56.4.823

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

1.  The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus.

Authors:  L F Lee; P Wu; D Sui; D Ren; J Kamil; H J Kung; R L Witter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.

Authors:  J M Reno; L F Lee; J A Boezi
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

3.  Structure-activity studies on phosphonoacetate.

Authors:  J C Mao; E R Otis; A M von Esch; T R Herrin; J S Fairgrieve; N L Shipkowitz; R G Duff
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

4.  Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien; A A Fondak; E Buimovici-Klein
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

5.  Comparative studies of interferon and three antiviral agents on neurotropic and oncogenic herpesviruses.

Authors:  M D Daniel; L A Falk; N W King; R Tamulevich; J S Holland; J G Bekesi
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

6.  Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells.

Authors:  Z Z Cui; L F Lee; J L Liu; H J Kung
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

7.  In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.

Authors:  J M Goodrich; K W Lee; H C Hinze
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

8.  Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.

Authors:  B I Lidin; E W Lamon
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.